Jason Murray Hulse, Co-Founder, CEO and Chairman of PACS Group, Inc., filed a Form 4 on October 30, 2026, disclosing the sale of 8,803 shares of common stock across two transactions on October 28 and October 29, 2026, pursuant to a Rule 10b5-1 trading plan.

Key Highlights

  • Two-day sale: Hulse disposed of 6,899 shares on October 28, 2026, and 1,904 shares on October 29, 2026, for a combined total of 8,803 shares.
  • Weighted average prices: The October 28 sale carried a weighted average price of $50.0977 per share; the October 29 sale carried a weighted average price of $50.0469 per share.
  • Price ranges: October 28 transactions ranged from $50.00 to $50.31 per share; October 29 transactions ranged from $50.00 to $50.225 per share.
  • Remaining ownership: Following the reported transactions, Hulse directly beneficially owned 54,179,397 shares of common stock.
  • 10b5-1 plan: Both sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Hulse on May 18, 2026.
  • Roles: Hulse is identified in the filing as a Director, 10% Owner, and Officer with the title Co-Founder, CEO and Chairman.

PACS Group CEO Hulse Executes Planned Share Sales Under May 2026 Trading Plan

According to the Form 4 filed with the U.S. Securities and Exchange Commission on October 30, 2026, Jason Murray Hulse, Co-Founder, CEO and Chairman of PACS Group, Inc. (NASDAQ:PACS), sold a total of 8,803 shares of common stock on October 28 and October 29, 2026. The filing indicates both transactions were coded "S" (open-market sale) and carried out under a Rule 10b5-1 trading plan that Hulse adopted on May 18, 2026.

On October 28, 2026, Hulse disposed of 6,899 shares at a weighted average price of $50.0977, with individual transactions occurring at prices ranging from $50.00 to $50.31 per share. The following day, October 29, 2026, he disposed of an additional 1,904 shares at a weighted average price of $50.0469, with individual transactions at prices ranging from $50.00 to $50.225 per share. The filing notes that both weighted average prices reflect multiple transactions and that full per-transaction detail is available upon request from the issuer, any security holder, or SEC staff.

After both disposals, Hulse's direct beneficial ownership of PACS Group common stock stood at 54,179,397 shares, as reported in the filing. The form was signed by Trevor Petersen as Attorney-in-Fact on October 30, 2026. No derivative securities were reported in Table II of the filing.

What Was Disclosed

The filing disclosed two open-market sales of PACS Group common stock by Co-Founder, CEO and Chairman Jason Murray Hulse on October 28 and October 29, 2026, totaling 8,803 shares, conducted under a pre-established Rule 10b5-1 trading plan adopted May 18, 2026.